Global Contrast Enhanced Ultrasound Market is set to capture over $2.6 Billion by 2030

Global Contrast Enhanced Ultrasound Market is set to
capture over $2.6 Billion by 2030

Inkwood Research analyzed that the Global Contrast Enhanced Ultrasound Market is anticipated to
record a 5.25% CAGR during the forecast period, 2022-2030.

“Browse 42 market data Tables and 40 Figures spread over 271 Pages, along with an in-depth TOC on
the Global Contrast Enhanced Ultrasound Market Forecast 2022-2030.”

VIEW TABLE OF CONTENT LINK - https://inkwoodresearch.com/reports/contrast-enhanced-ultrasound-
market/#table-of-contents

Contrast enhanced ultrasound (CEUS) employs contrasting ultrasound media to traditional sonography
used for medical purposes. Ultrasound contrast agents depend on different sound waves that are
reflected between substances and interfaces. These reflections can be anything from a bubble surface to
a complex structure. Compared to traditional ultrasound technologies, contrast enhanced ultrasounds
are patient-friendly, radiation-free, and cost-efficient. Moreover, the increasing prevalence of liver,
kidney, and vascular & gastrointestinal diseases globally is expected to propel the demand for contrast
enhanced ultrasound services. In addition, the high demand for technologically advanced medical
devices is anticipated to stimulate the growth of the global contrast enhanced ultrasound market during
the forecast period.

REQUEST FREE SAMPLE LINK - https://inkwoodresearch.com/reports/contrast-enhanced-ultrasound-
market/#request-free-sample

Technological Advancements propel Market Growth

Contrast enhanced ultrasound imaging is employed globally in many off-label and clinically approved
applications. Cutting-edge technological advancements in this area, including contrast agent synthesis,
device development, image processing techniques, design of novel pulse sequences, and the
development of remote monitoring for ultrasound therapeutics, drive market growth.

The prevalence of chronic illnesses, including multimorbidity, is rising as the population ages. Further,
urbanization quickens, the middle class expands, and individuals lead increasingly immobile lifestyles. As
a result, the health systems are under pressure, and public health initiatives advise people to get regular
screening exams to determine if they have certain chronic conditions, including cancer, diabetes,
cardiovascular disease, etc. Therefore, the market is projected to grow in contrast-enhanced ultrasound
diagnostic screenings.

Targeted Type set to Lead the Market

Therapeutic agents are either placed onto the contrast agent’s shell or encapsulated in targeted-type
contrast agents. The contrast agents release the active medicine as it reaches the target site, increasing
bioavailability. This phenomenon is being extensively researched globally to determine how it might be
used to treat serious diseases, including cancer and cardiovascular disease.

Additionally, several clinical investigations involving the delivery of DNA and nucleic acids using contrast-
enhanced ultrasound technology have been completed. To boost its DNA binding affinity, one
commercially available ultrasonic contrast agent named Definity has lengthened its chain and added
charged radicals to its shell. As a result, the segment is expected to increase thanks to several potential
targeted ultrasound agent progenies in the clinical and preclinical stages.

North America Expected to capture Highest Market Shares

Rising cases of chronic illness and the urgency for early diagnosis and detection propel the studied
market toward growth. In North America, contrast-enhanced ultrasound is predominantly used in
cardiac and abdominal imaging. Moreover, a rising number of training and education programs for
radiologists regarding the diagnostic & therapeutic use of contrast-enhanced ultrasound is expected to
boost the region’s growth over the forecast period.

The market is highly fragmented due to numerous multinational and regional companies. The sector is
dominated by a few players, accounting for the majority of the revenue. Competitive strategies
employed by players include partnerships, mergers & acquisitions, and frequent launches of products
with upgraded functions. Thus, the competitive rivalry in the market is likely to remain high during the
forecast period.

Request for Customization: https://inkwoodresearch.com/request-for-custom-report/

About Inkwood Research
Inkwood Research specializes in syndicated & customized research reports and consulting services.
Market intelligence studies with relevant fact-based research are customized across industry verticals
such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective
comprehension that acknowledges the business environments. Our geographical analysis comprises
North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.

Contact Us
https://www.inkwoodresearch.com
[email protected]
1-(857)293-0150

Related Reports:
GLOBAL CARDIOVASCULAR ULTRASOUND MARKET
GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET
GLOBAL VETERINARY DIAGNOSTICS MARKET